Kálmán Tóth

14.9k total citations · 1 hit paper
185 papers, 4.8k citations indexed

About

Kálmán Tóth is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kálmán Tóth has authored 185 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Cardiology and Cardiovascular Medicine, 53 papers in Surgery and 53 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kálmán Tóth's work include Blood properties and coagulation (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (15 papers). Kálmán Tóth is often cited by papers focused on Blood properties and coagulation (46 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Antiplatelet Therapy and Cardiovascular Diseases (15 papers). Kálmán Tóth collaborates with scholars based in Hungary, United States and United Kingdom. Kálmán Tóth's co-authors include Gábor Késmárky, Róbert Halmosi, Eszter Szabados, Balázs Sümegi, P. Kenyeres, Gergely Fehér, Miklós Rábai, László Czopf, Tamás Habon and Katalin Koltai and has published in prestigious journals such as The Lancet, Blood and PLoS ONE.

In The Last Decade

Kálmán Tóth

174 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

2017 469 citations Kálmán Tóth et al. profile →

Peers

Countries citing papers authored by Kálmán Tóth

Since Specialization

Citations

This map shows the geographic impact of Kálmán Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kálmán Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kálmán Tóth more than expected).

Fields of papers citing papers by Kálmán Tóth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kálmán Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kálmán Tóth. The network helps show where Kálmán Tóth may publish in the future.

Co-authorship network of co-authors of Kálmán Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Kálmán Tóth. A scholar is included among the top collaborators of Kálmán Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kálmán Tóth. Kálmán Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence and Cardiopulmonary Characteristics of Post-COVID Syndrome at a Hungarian Tertiary Referral Hospital 2025 ·Journal of Clinical Medicine ·(unknown), Barbara Sándor, (unknown), Anita Pálfi, (unknown), László Deres, Eszter Szabados, László Czopf, Miklós Rábai, (unknown), Tamás Alexy, Tamás Habon, Kálmán Tóth, Hussain Alizadeh, (unknown), Róbert Halmosi	0
2	The Role of Ranolazine in the Treatment of Ventricular Tachycardia and Atrial Fibrillation: A Narrative Review of the Clinical Evidence 2024 ·Biomedicines ·(unknown), (unknown), Tamás Alexy, Kálmán Tóth, László Czopf	0
3	Cardiac effects of OPA1 protein promotion in a transgenic animal model 2024 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Kata Juhász, (unknown), Katalin Fekete, Ferenc Gallyas, Kálmán Tóth, Róbert Halmosi, László Deres	2
4	Screening for Peripheral Artery Disease Using an Automated Four-Limb Blood Pressure Monitor Equipped with Toe–Brachial Index Measurement 2023 ·Journal of Clinical Medicine ·(unknown), Katalin T. Biró, D. Endrei, Katalin Koltai, Barbara Sándor, Kálmán Tóth, Gábor Késmárky	1
5	Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication 2023 ·Biomedicines ·Katalin T. Biró, Barbara Sándor, (unknown), Katalin Koltai, (unknown), D. Endrei, (unknown), Kálmán Tóth, Gábor Késmárky	2
6	Oscillometric measurement of the ankle-brachial index and the estimated carotid-femoral pulse wave velocity improves the sensitivity of an automated device in screening peripheral artery disease 2023 ·Frontiers in Cardiovascular Medicine ·(unknown), Katalin T. Biró, D. Endrei, Katalin Koltai, Barbara Sándor, Kálmán Tóth, Gábor Késmárky	4
7	Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes 2023 ·International Journal of Molecular Sciences ·(unknown), Barbara Sándor, Zita Bognár, (unknown), Anita Pálfi, (unknown), Kálmán Tóth, Eszter Szabados	14
8	Substance Use-Associated Mortality among Heart Donors after the COVID-19 National Emergency Increased but Did Not Affect Peri-Transplant Outcomes 2023 ·Journal of Cardiovascular Development and Disease ·(unknown), (unknown), Scott Jackson, Thanat Chaikijurajai, Róbert Halmosi, Kálmán Tóth, (unknown), Tamás Alexy	2
9	The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results 2021 ·International Journal of Molecular Sciences ·(unknown), László Deres, Kálmán Tóth, Róbert Halmosi, Tamás Habon	77
10	Functional and structural adaptations of the coronary macro- and microvasculature to regular aerobic exercise by activation of physiological, cellular, and molecular mechanisms: ESC Working Group on Coronary Pathophysiology and Microcirculation position paper 2021 ·Cardiovascular Research ·Ákos Koller, M. Harold Laughlin, Edina Cenko, Cor de Wit, Kálmán Tóth, Raffaele Bugiardini, (unknown), Marija Vavlukis, Olivia Manfrini, (unknown), Gabriella Dörnyei, Teresa Padró, Lina Badimón, Dimitris Tousoulis, Stephan Gielen, Dirk J. Duncker	29
11	BGP‐15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats 2021 ·Oxidative Medicine and Cellular Longevity ·(unknown), (unknown), (unknown), László Deres, Ferenc Gallyas, Balázs Sümegi, Kálmán Tóth, Róbert Halmosi	15
12	Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure 2020 ·Antioxidants ·(unknown), László Deres, (unknown), Krisztián Erős, Barbara Sándor, Péter Urbán, (unknown), Zsolt Márton, Balázs Sümegi, Kálmán Tóth, Tamás Habon, Róbert Halmosi	40
13	The Role of Adjuvant Vinpocetine Therapy in Aspirin-Treated Cerebrovascular Patients 2020 ·Gergely Fehér, Péter Csécsei, Judit Papp, P. Kenyeres, Gábor Késmárky, Miklós Rábai, Antal Tibold, Kálmán Tóth, László Szapáry	2
14	Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol 2020 ·Cardiovascular Therapeutics ·(unknown), (unknown), P. Kenyeres, Miklós Rábai, Kálmán Tóth, Róbert Halmosi, Tamás Habon	24
15	Haemorheological and haemostatic alterations in coeliac disease and inflammatory bowel disease in comparison with non-coeliac, non-IBD subjects (HERMES): a case–control study protocol 2019 ·BMJ Open ·Zsolt Szakács, (unknown), P. Kenyeres, Patrícia Sarlós, Bálint Erőss, (unknown), Ãgnes Nagy, (unknown), (unknown), Nelli Farkas, (unknown), Katalin Márta, Andrea Szentesi, Margit Tökés‐Füzesi, Tímea Berki, Áron Vincze, Kálmán Tóth, Péter Hegyi, Judit Bajor	4
16	Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model 2017 ·Oxidative Medicine and Cellular Longevity ·(unknown), László Deres, Balázs Sümegi, Kálmán Tóth, Eszter Szabados, Róbert Halmosi	97
17	Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations 2015 ·BMC Genetics ·Ãgnes Nagy, Csilla Sipeky, (unknown), Béla Melegh, (unknown), (unknown), Kálmán Tóth	12
18	OFLOXACIN LOADED, IN-SITU - GELLING, CALCIUM ALGINATE HYDROGEL IN THE LOCAL TREATMENT OF BONE AND SOFT TISSUE INFECTIONS IN ORTHOPAEDIC SURGERY 2012 ·FARMACIA ·(unknown), (unknown), Kálmán Tóth, Piroska Szabó‐Révész, Edit Urbán, Erzsébet Csányi	1
19	Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters 2010 ·Blood ·Bence György, Károly Módos, Éva Pállinger, Krisztina Pálóczi, Mária Pásztói, Petra Misják, Mária A. Deli, Áron Sipos, Anikó Szalai, István Voszka, A. A. Polgar, Kálmán Tóth, Mária Csete, György Nagy, Steffen Gay, András Falus, Ágnes Kittel, Edit I. Buzás	342
20	Low hematocrit per blood viscosity ratio as a mortality risk factor in coronary heart disease. 2008 ·PubMed ·P. Kenyeres, I. Juricskay, (unknown), Gábor Késmárky, Diána Mühl, Kálmán Tóth, Lajos Bogár	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact